- $68.53bn
- $73.06bn
- $8.54bn
- 99
- 17
- 30
- 46
Annual income statement for Zoetis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,260 | 6,675 | 7,776 | 8,080 | 8,544 |
| Cost of Revenue | |||||
| Gross Profit | 4,284 | 4,630 | 5,491 | 5,634 | 6,021 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 4,459 | 4,679 | 5,288 | 5,424 | 5,608 |
| Operating Profit | 1,801 | 1,996 | 2,488 | 2,656 | 2,936 |
| Net Income Before Taxes | 1,801 | 1,996 | 2,488 | 2,656 | 2,936 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,500 | 1,636 | 2,034 | 2,111 | 2,340 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,500 | 1,638 | 2,037 | 2,114 | 2,344 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,500 | 1,638 | 2,037 | 2,114 | 2,344 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.17 | 3.52 | 4.41 | 4.58 | 5.16 |
| Dividends per Share |